80
Participants
Start Date
December 8, 2023
Primary Completion Date
February 5, 2025
Study Completion Date
March 27, 2025
TQC2731 injection
TQC2731 injection is a thymic stromal lymphopoietin (TSLP) monoclonal antibody.
TQC2731 matching placebo
It'a a placebo injection without active substances.
Affiliated Zhongshan Hospital Of Dalian University, Dalian
Eye & ENT Hospital of Fudan University, Shanghai
The Affiliated Hospital of Xuzhou Medical University, Xuzhou
The First Affiliated Hospital of Wannan Medical College, Wuhu
Weifang Second People's Hospital, Weifang
The Affiliated Hospital of Qingdao University, Qingdao
ZhuJiang Hospital of Southern Medical University, Guangzhou
The Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai
Jieyang People's Hospital, Jieyang
Affiliated Hospital of Zunyi Medical University, Zunyi
Chengdu Second People's Hospital, Chengdu
West China Hospital of Sichuan University, Chengdu
The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an
The First Affiliated Hospital of Xinjiang Medical University, Ürümqi
Cangzhou Central Hospital, Cangzhou
Affiliated Hospital of Inner Mongolia Medical University, Hohhot
Lead Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
INDUSTRY